OKYO Hits Multiple Dry Eye Endpoints, Plans Move Into Phase III

 
• By Joseph Haas
  
eye%20drops.jpg
OKYO plans to take its dry eye candidate into Phase III
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D